Acne-Prone Skin

Treat acne while maintaining the skin barrier.

In patients with acne, a compromised skin barrier and low ceramide levels leave the skin susceptible to bacteria, dryness, and irritation. Harsh acne treatments further aggravate the skin.1,2

Ceramide-containing cleansers are associated with a lower risk of irritation and can improve skin barrier function, which may enhance patient adherence to acne treatment.3
CeraVe Acne Foaming Cream Cleanser is gentle yet effective, treating acne while maintaining the skin barrier.
CONTROL & PREVENT ACNE
  • 4.0% benzoyl peroxide: an ingredient proven to reduce C. acnes without bacterial resistance4,5
  • pH level of 5.5: levels of less than 6 are shown to markedly reduce C. acnes growth1
HYDRATE & MAINTAIN SKIN
  • Ceramides 1, 3, & 6-II help maintain and restore the skin’s natural protective barrier
  • Hyaluronic acid helps retain moisture
  • Niacinamide (vitamin B3) soothes the skin
Products set

Try our products before recommending

Sign up to receive our free full-size product kit

Benzoyl peroxide (BPO) is widely studied and has proven to be one of the most versatile, safe, inexpensive, and effective acne therapies.6
CeraVe 4% BPO aligns with AAP guidelines for mild, moderate, and severe acne treatment.
Higher BPO concentrations, such as 10%, may provide minimal additional efficacy and can result in increased drying and irritation.6
Both cleansers and leave-on formulations of BPO have proven effective at reducing the growth of C. acnes.7
Ceramide deficiency and acne
Ceramides are lipids that form the skin barrier and help retain moisture.2 When ceramide levels are low, moisture escapes through the skin barrier. Low ceramide levels leave the skin susceptible to dryness, irritation, and proliferation of the inflammatory C. acnes.8
In a clinical study, acne patients presented lower levels of ceramides and diminished water barrier function.9

Recommend a gentle yet effective acne regimen to enhance Rx adherence

CLEANSE & TREAT CeraVe Acne Foaming Cream Cleanser
TREAT Prescription medication
MOISTURIZE & PROTECT AM Facial Moisturizing Lotion
PM Facial Moisturizing Lotion
Ultra-Light Moisturizing Lotion

Featured Products

Acne Foaming Cream Cleanser

Formulated with 4% benzoyl peroxide and ceramides 1, 3, & 6-II to treat acne while maintaining the skin barrier.

VIEW MORE DETAILS

AM Facial Moisturizing Lotion

Designed to protect against UVA/UVB, help restore the protective skin barrier, and provide up to 24 hours of hydration.

VIEW MORE DETAILS

PM Facial Moisturizing Lotion

Developed with ceramides 1, 3, & 6-II, hyaluronic acid, and niacinamide to hydrate and calm the skin while helping to restore the skin’s natural barrier.

VIEW MORE DETAILS

Resurfacing Retinol Serum

Formulated with encapsulated retinol to help reduce the appearance of post-acne marks, plus licorice root extract to help brighten skin’s appearance.

VIEW MORE DETAILS

Ultra-Light Moisturizing Lotion SPF 30

Designed to protect against UVA/UVB, help restore the protective skin barrier, and provide up to 24 hours of hydration, with an ultra-light matte finish.

VIEW MORE DETAILS
REFERENCES: 1. Ali SM, Yosipovitch G. Skin pH: from basic science to basic skin care. Acta Derm Venereol. 2013;93(3):261-267. 2. Sahle FF, Gebre-Mariam T, Dobner B, Wohlrab J, Neubert RH. Skin diseases associated with the depletion of stratum corneum lipids and stratum corneum lipid substitution therapy. Skin Pharmacol Physiol. 2015;28(1):42-55. 3. Lynde CW, Andriessen A, Barankin B, et al. Moisturizers and ceramide-containing moisturizers may offer concomitant therapy with benefits. J Clin Aesthet Dermatol. 2014;7(3):18-26. 4. Zeichner JA. Inflammatory acne treatment: review of current and new topical therapeutic options. J Drugs Dermatol. 2016;15(1, Suppl 1):s11-s16. 5. Thiboutot D, Del Rosso JQ. Acne vulgaris and the epidermal barrier: Is acne vulgaris associated with inherent epidermal abnormalities that cause impairment of barrier functions? Do any topical acne therapies alter the structural and/or functional integrity of the epidermal barrier? J Clin Aesthet Dermatol. 2013;6(2)18-24. 6. Eichenfield LF, Krakowski AC, Piggott C, et al.; American Acne and Rosacea Society. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013 May;131 Suppl 3:S163-86. doi:10.1542/peds.2013-0490B. PMID: 23637225. 7. Del Rosso JQ. Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data. Cutis. 2008;82(5):336-342. 8. Dréno B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017;31(Suppl 5):8-12. 9. Yamamoto A, Takenouchi K, Ito M. Impaired water barrier function in acne vulgaris. Arch Dermatol Res. 1995;287(2):214-218.